AC Immune SA
ACIU
$2.39
-$0.05-2.05%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -5.36M | -17.15M | -18.73M | -18.93M | -19.48M |
| Total Depreciation and Amortization | 626.80K | 621.60K | 601.80K | 616.00K | 628.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.96M | 936.30K | 1.91M | 1.74M | 1.17M |
| Change in Net Operating Assets | -16.51M | 528.70K | 514.00K | -1.59M | -401.00K |
| Cash from Operations | -18.29M | -15.06M | -15.70M | -18.16M | -18.08M |
| Capital Expenditure | -187.50K | -317.00K | -172.40K | -216.10K | -42.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 26.48M | 5.66M | -5.56M | 46.47M | 5.19M |
| Cash from Investing | 26.29M | 5.34M | -5.73M | 46.25M | 5.15M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -139.00K | -139.00K | -135.00K | -135.00K | -143.00K |
| Issuance of Common Stock | 41.17M | 574.00K | 2.06M | -- | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 13.00K | -7.00K | -6.00K | -8.00K |
| Cash from Financing | 46.33M | 507.20K | 2.13M | -152.40K | -156.90K |
| Foreign Exchange rate Adjustments | -1.75M | 58.90K | -79.00K | -10.80K | -330.40K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 52.59M | -9.15M | -19.39M | 27.93M | -13.42M |
